Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
Katta, Varun, O’Keefe, Kiera, Li, Yichao, Mayuranathan, Thiyagaraj, Lazzarotto, Cicera R., Wood, Rachael K., Levine, Rachel M., Powers, Alicia, Mayberry, Kalin, Manquen, Garret, Yao, Yu, Zhang, Jingjing, Jang, Yoonjeong, Nimmagadda, Nikitha, Dempsey, Erin A., Lee, GaHyun, Uchida, Naoya, Cheng, Yong, Fazio, Frank, Lockey, Tim, Meagher, Mike, Sharma, Akshay, Tisdale, John F., Zhou, Sheng, Yen, Jonathan S., Weiss, Mitchell J., Tsai, Shengdar Q.
Published in Molecular therapy (02.10.2024)
Published in Molecular therapy (02.10.2024)
Get full text
Journal Article
(+)-Dehydroabietylamine derivatives target triple-negative breast cancer
Ling, Taotao, Tran, My, González, Miguel A., Gautam, Lekh Nath, Connelly, Michele, Wood, Rachael K., Fatima, Iram, Miranda-Carboni, Gustavo, Rivas, Fatima
Published in European journal of medicinal chemistry (18.09.2015)
Published in European journal of medicinal chemistry (18.09.2015)
Get full text
Journal Article
In vivo Treatment of a Severe Vascular Disease via a Bespoke CRISPR-Cas9 Base Editor
Alves, Christiano R R, Das, Sabyasachi, Krishnan, Vijai, Ha, Leillani L, Fox, Lauren R, Stutzman, Hannah E, Shamber, Claire E, Kalailingam, Pazhanichamy, Mccarthy, Siobhan, Lino Cardenas, Christian L, Fong, Claire E, Imai, Takahiko, Mitra, Sunayana, Shuqi Yun, Wood, Rachael K, Benning, Friederike M C, Lawton, Joseph, Kim, Nahye, Silverstein, Rachel A, Joana Ferreira Da Silva, De La Cruz, Demitri, Richa, Rashmi, Malhotra, Rajeev, Chung, David Y, Chao, Luke H, Tsai, Shengdar Q, Maguire, Casey A, Lindsay, Mark E, Kleinstiver, Benjamin P, Musolino, Patricia L
Published in bioRxiv (11.11.2024)
Published in bioRxiv (11.11.2024)
Get full text
Paper